Cimispect 250mg/250mg Injection
Marketer
Chandra Bhagat Pharma Pvt Ltd
Salt Composition
Imipenem (250mg) + Cilastatin (250mg)
Overview Cimispect 250mg/250mg Injection
Combiflox 250mg/250mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by a healthcare provider, this medication targets infectious microorganisms to curtail infection spread. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Typical side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain) which usually resolve spontaneously. Severe or persistent side effects warrant immediate medical attention. Seek immediate help for allergic reactions (skin eruptions, itching, edema, respiratory distress). Prior to use, inform your physician of all current medications and pre-existing conditions. Pregnant or lactating individuals require specific medical consultation before initiating treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing somnolence or dizziness.
Primary Ingredients of Cimispect 250mg/250mg Injection
No text was provided. Please provide the text you would like me to rephrase.
Uses of Cimispect 250mg/250mg Injection
Life-threatening bacterial infestations
Major Benefits of Cimispect 250mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cimispect 250mg/250mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Cimispect 250mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cimispect 250mg/250mg Injection works:
Cimispect Injection, containing 250mg each of Imipenem and Cilastatin, utilizes a dual-drug approach to combat bacterial infection. Imipenem's antibiotic action disrupts bacterial cell wall synthesis, compromising bacterial survival. Cilastatin, a dehydropeptidase I inhibitor, safeguards Imipenem from enzymatic degradation (by dehydropeptidase I), thus extending its therapeutic efficacy within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of consuming alcohol while using Cimispect 250mg/250mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cimispect 250mg/250mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Cimispect 250mg/250mg is likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Cimispect 250mg/250mg Injection can induce adverse reactions potentially impairing driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), may compromise some patients' ability to operate a vehicle.
KidneyCAUTION
For individuals with impaired kidney function, administering Cimispect 250mg/250mg Injection requires careful consideration. A modified dosage of Cimispect 250mg/250mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Cimispect 250mg/250mg Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Cimispect 250mg/250mg Injection :
Omitting a scheduled dose of Cimispect 250mg/250mg Injection warrants immediate physician consultation.
Facts to Know About Cimispect 250mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
3,018 People bought this recently